As Twist1 is critical in promoting EMT and metastasis in HCC cells, the identification of a novel compound targeting Twist1 and its underlying mechanism of action could provide valuable insights into the development of improved therapeutic strategies for HCC. The gene discussed is TWIST1; the disease is hepatocellular carcinoma.